Azelby Robert bought TNGX
June 19, 2026 · Form 4 insider transaction
Azelby Robert bought 5,740 shares of Tango Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,740
Price
$0.00
Total value
N/A
InsiderAzelby Robert
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 19, 2026
Filing dateJune 23, 2026
Shares owned after5,740
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments following the grant date, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.